PhaseV to Present on Advanced AI/ML for Clinical Development at Upcoming Biopharma Events

Presentations to Demonstrate How Next-Generation Bayesian and Causal AI Increase Flexibility and Speed in Clinical Development BOSTON, Sept. 15, 2025 /PRNewswire/ -- PhaseV, a leader in AI/ML for clinical development, today announced it will participate in several upcoming biopharma...